Milnacipran is a dual serotonin-norepinephrine reuptake inhibitor (SNRI) in use in Europe, Asia and Australia. Its norepineprine:serotonin effects are 3:1, in contrast to other SNRIs (e.g. venlafaxine, with a 1:30 norepineprine:serotonin ratio).
It takes 30 seconds or login using your email address
Please enter the email address that you registered the newsletter with